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We have all had this experience. The patient sits before usaccompanied by a family member during a preoperativeoffice visit, denying any cognitive problems after a signifi-cant cardiac event. The gestures from the family member inthe background of the office indicate something quite dif-ferent. “Oh no, I’m doing fine,” the patient says, despite
occupational, financial, social, and sexual dysfunction. However, when we ask
about the children and grandchildren, the room suddenly becomes humid. So, what
is all the concern about any relationship between the head and the heart? According
to our patient, there is not any.
If we are to explain this cardiocognitive connection, much will depend on further
exploration of physiologic parameters and not just new surgical techniques. Neu-
ropsychology can further the contribution to cardiothoracic surgery in this area.
Balancing variable selection, design, statistical manipulation, and assessment of the
relevant outcome is a tough accomplishment. The current article by Taggart and
colleagues1 does just that, isolating a variable, blood gas levels, to assess the
relationship between preoperative and postoperative cognitive dysfunction.
Use of parametric statistics over incident reports, frequency, or descriptive
statistics alone carries more power in assessing clinical outcome and applicability.
Parametric analyses with an established confidence level at a P value of less than .05
or less than .01 will assist interpretation. Most medical research accepts results at a
P value of less than .05. The use of standardized scores, z scores, allows researchers
to compare measures over time.2-4
Investigators usually establish an interpretation of clinically meaningful change
a priori. The use of standardized scores, patient self-reports, and collateral data from
family members or significant others will help to convey clinically meaningful
information. Studies do establish a 1 to 1.5 SD of change as significant.5 Others
accept a 20% difference within 20% of the tests administered and with given control
group comparisons. A 20% of 20% formula works well if the battery is compre-
hensive.6 With abbreviated batteries, we risk the overacceptance of minimal change.
A 2-SD change strengthens conclusions.
If we reject the null hypothesis when it should actually be accepted, we are
risking a type I error. Conversely, if we accept the null hypothesis and it should be
rejected, we are risking a type II error. An acceptable confidence level established
before the research study governs the acceptance or rejection of the null hypothesis.
It is most important to gear the project design to prevent a type I error. Establishing
strict confidence levels, controlling for confounding variables, and obtaining a large
heterogeneous sample size strengthens the cardiocognitive connection.
The growing interest in neurobehavioral implications associated with cardiac
illness and neuroprotective procedures over the past decade has expanded the need
for cognitive testing before and after cardiovascular surgery.7,8 Recommendations
for the inclusion of neuropsychological testing with cardiovascular research have
been established.5,9-11 These recommendations include the following: (1) perform
preoperative and postoperative cognitive testing; (2) avoid immediate postoperative
measures because of the influence of physiologic and pharmacologic effects; and (3)
analyze individual differences in performance rather than group differences. Al-
though these recommendations have been accepted, differences still exist from
center to center in the selection of cognitive measures, the appropriate timing of
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postoperative testing, the variables being controlled, and the
clinical definition and acceptable level of significance.
Advances in cardiac technology and techniques have
overshadowed a concern for cognitive functioning and its
effect on daily life. A reliable and consistent methodology
must be established to understand the effect of cognitive
functioning on daily life. For most research, nothing beats a
good, tight preprocedure-postprocedure design with a large
subject pool, but for current purposes, this is impractical and
not always useful. Where ethics and procedures allow,
double blinding and randomization equalizes individual dif-
ferences and increases generalizability. Studies controlling
for comorbid medical conditions and neurologic history will
allow us to isolate the effect of the cardiac procedure on
cognitive functioning. The strength of cardiothoracic neu-
robehavioral studies lies in establishing controls for physi-
cal and neurologic conditions.
There are a number of external design concerns when
considering drawing up a neuropsychological protocol. The
first are the physical limitations and restrictions of the
deconditioned cardiac patients. Patient deconditioning af-
fects timed tests, motor skills, and processing speed. Patient
performance will be affected by variables such as function
of hemodynamic status, use of anesthetic and psychotropic
agents, metabolic rates, infusion lines, and level of aware-
ness. Postoperative upper extremity motor speed will be
disrupted after the insertion and removal of infusion lines.
Second, the testing timetable, or when cognitive testing
occurs before and after procedures, is an important consid-
eration. Centers should establish a standard time for base-
line testing. Postoperative testing results obtained too early
within the recuperative phase can be misleading. For exam-
ple, comparing reexamination results between patients un-
dergoing off-pump or on-pump bypass the first week after
surgical intervention with comorbid medical conditions
might reflect a wider range of cognitive differences. A
reexamination schedule compared with baseline testing
comparison at discharge, 6 months, and 12 months offers
adequate recovery and physical stabilization.5 Extending the
follow-up will increase the lost-to-follow-up percentage and
the risk of other pathophysiologic changes, especially in
elderly patients.
Third, the inability to control for testing conditions is
another threat to the design. Most commonly, these are
bedside versus laboratory, inpatient versus outpatient, early
versus late in the hospitalization, patients having several
procedures versus those having no previous procedures
while in the hospital, and with versus without achievement
of metabolic stabilization.
A brief neuropsychological review of 45 to 60 minutes
either at bedside, in the neuropsychology laboratory, or both
is realistic given competition for the patient’s time. The
testing is conducted by a neuropsychologist or a technician
supervised by a neuropsychologist. The testing of cognitive
domains includes standardized internationally acceptable
measures in which established norms for specific medical
control groups exist. Because patients can be their own
control subjects and are retested over time, test-retest reli-
ability needs to be acceptable. A selection of the tests
emphasizing specificity, sensitivity, availability of alterna-
tive or parallel test forms, and a balanced review of cogni-
tive domains represents the core battery for administration.
These common cognitive domains include the following:
attention-concentration, auditory and visual memory, mo-
tor, visual-spatial, abstract-executive, processing speed, and
language functions. Collateral information from the family
or significant others regarding the activities of daily living
strengthens outcome perspectives.
A selection of the cognitive domains and sampling of
measures includes the following: Attention/Concentration-
Wechsler Memory Scale-R/III12,13; Information and Orien-
tation; Wechsler Adult Intelligence Test-R/III14,15; Digit
Span and Digit Symbol; Trail Making A and B16; Auditory
and Visual Memory-Wechsler Memory Scale-R/III, Audi-
tory and visual sections with delay; Benton Visual Reten-
tion Test17; Rey Auditory-Verbal Learning Test18; Califor-
nia Verbal Learning Test19; Hopkins Verbal Learning
Test20;Motor-Finger Tapping and Grip Strength16; Grooved
Pegboard Test21; Visual/Spatial-Rey Complex Figure
Test22; Wechsler Adult Intelligence Test-R/III, Block De-
sign; Clock Drawing23; Abstract/Executive—The Stoop
Test24; Booklet Category Test25; Processing Speed-Wech-
sler Adult Intelligence Test-R/III, Digit Symbol, Symbol
Search; Trail Making A and B; Language subtests of Boston
Diagnostic Aphasia Examination26; Boston Naming Test27;
Controlled Oral Word Association Test28; and Collateral
Information-Sickness Impact Profile.29
Is there is a difference between clinically meaningful and
statistically meaningful? In medical populations we often
get statistically significant data but somehow miss informa-
tion that is clinically useful. This can be more easily ex-
plained with the examples of pre-examinations and postex-
aminations. Two patients who score in the impaired range in
memory functioning on post-testing might present different
clinical challenges. For one patient, the deficits might be of
long-standing duration evident on the pretest. This patient
and his or her family have compensated and need no addi-
tional help with care. In the other patient the new-onset
cognitive problems will drastically affect his or her fol-
low-up performance in areas like self-care, family care, or
return to work.
Finding our way from the heart to the head to assist
patient understanding can be accomplished by staying fo-
cused on physiologic parameters, tightening the methods,
and using a balanced cognitive domain review. Including
collateral family perspectives will strengthen the outcome.
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